Rudy Mazzocchi

CEO, President and Chairman of the Board

As Chairman/Acting-CEO of AGENTIX Corp., Rudy concurrently serves as Executive Chairman of ASEP Medical, Inc. (CSE:ASEP.CN), Executive Chairman of MY NEXT HEALTH and Independent Director of several private and public, early and growth-stage companies, and Senior Advisor to a variety of international corporations seeking global expansion and/or access to U.S. public markets. Mazzocchi previously served as Executive Chairman of Establishment Labs (NASDAQ:ESTA) and Independent Director of Greatbatch/Integer Medical (NYSE:ITGR).

Martin Schroeder, MSC

Chief Scientific Officer

Martin has over 25 years of successful experience in general management, technical R&D management, marketing, corporate finance and business development. Martin is a founder of  Intercept Pharmaceuticals and has contributed to the success of companies such as @POS, Dow Chemical, Immunex, Medicine Planet, Cyrano Sciences, Gamera Bioscience, MetaXen, Vistagen, Bethesda Pharmaceuticals, Acacia Biosciences, Maxim Biotech, Invivogen, Optigon Technology, Primex Physics International and many others.

Salman Hoda

SVP Portfolio & Business Development

Salman brings nearly two decades of pharma experience to Agentix where he has held various roles spanning several areas. In addition, he has over ten years of business development experience with several organizations including Apotex, and led portfolio management activities for its hematology / oncology division, Apobiologix. He has led activities for several clients including the identification, valuation and negotiation of pharmaceutical assets at various development stages.

David Fiene


With over 30 years of experience, David has served as CFO and financial advisor for various public and private companies. His experience started with PWC and was instrumental in the public offering of MFlex, and went on to lead the Advantage Accounting Group. He is a member of the American Institute of Certified Public Accountants.